UniProtKB/Swiss-Prot Q9Y5S8: Variant p.Pro330Ser

NADPH oxidase 1
Gene: NOX1
Feedback?

Variant information Variant position:

330 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:

US The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Proline (P) to Serine (S) at position 330 (P330S, p.Pro330Ser). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:

Change from medium size and hydrophobic (P) to small size and polar (S) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:

-1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page
Variant description:

Found in a patient with very early onset inflammatory bowel disease; uncertain significance; no effect on subcellular location; significantly reduced basal and phorbol ester-stimulated ROS generation, which may decrease resistance to infection by enteric pathogens, such as Campylobacter jejuni. Any additional useful information about the variant.

Sequence information Variant position:

330 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:

564 The length of the canonical sequence.
Location on the sequence:

LQMNKRGFSMEVGQYIFVNC P SISLLEWHPFTLTSAPEEDF The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         LQMNKRGFSMEVGQYIFVNCPSISLLEWHPFTLTSAPEEDF

Mouse                         LQMRKRGFSMEVGQYIFVNCPSISFLEWHPFTLTSAPEEEF

Rat                           LQMRKRGFTMGIGQYIFVNCPSISFLEWHPFTLTSAPEEEF

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	1 – 564	NADPH oxidase 1
Topological domain	228 – 396	Extracellular
Domain	284 – 391	FAD-binding FR-type
Alternative sequence	191 – 564	Missing. In isoform NOH-1S.

Literature citations
Defects in NADPH oxidase genes NOX1 and DUOX2 in very early onset inflammatory bowel disease.
Hayes P.; Dhillon S.; O'Neill K.; Thoeni C.; Hui K.Y.; Elkadri A.; Guo C.H.; Kovacic L.; Aviello G.; Alvarez L.A.; Griffiths A.M.; Snapper S.B.; Brant S.R.; Doroshow J.H.; Silverberg M.S.; Peter I.; McGovern D.P.; Cho J.; Brumell J.H.; Uhlig H.H.; Bourke B.; Muise A.A.; Knaus U.G.;
Cell. Mol. Gastroenterol. Hepatol. 1:489-502(2015)
Cited for: POSSIBLE INVOLVEMENT IN INFLAMMATORY BOWEL DISEASE; VARIANTS SER-330 AND ASN-360; SUBCELLULAR LOCATION;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.